Nicholas Benedict

Nicholas has over 20 years experience in the pharma industry, starting in finance in F. Hoffmann-La Roche before moving to marketing and sales. Roles included Global Head of Anti-infectives Business Unit at Novartis AG in Switzerland, COO of Novartis UK, Chief Commercial Officer at Basilea Pharmaceutica where he successfully co-led the company’s follow-on offering raising over CHF320 million and CEO of Swiss start-up Lumavita AG.